Combination therapy for treatment of multiple sclerosis.
F D
FD
Lublin
S C
SC
Reingold
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D018849:Controlled Clinical Trials as Topic; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D000068717:Glatiramer Acetate; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000008:administration & dosage*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012008:Recurrence
D000276:Adjuvants, Immunologic; D010455:Peptides; D011994:Recombinant Proteins; D000068576:Interferon beta-1b; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D000068556:Interferon beta-1a